HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
Smith+Nephew: Reports Publication of New Research in Wounds International
Clinicians reported a decline in-home visits and an increase in remote care via digital communication tools such as video calls, text and email.
Intersect ENT EXPAND Post-Market Study Evaluating Longer-Term Outcomes of PROPEL® Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation
EXPAND is a prospective, randomized, single-blind, intra-patient controlled, post-market clinical trial enrolling approximately 80 patients in the United States.
Procedure-Related Techniques and Care Pathways from the OPTIMIZE PRO Clinical Study Show Promising Early Outcomes for Patients Implanted with the Medtronic Evolut™ TAVR System
The interim data was presented virtually at the Society for Cardiovascular Angiography and Interventions (SCAI) 2021 Scientific Sessions.
MindRhythm Announces Launch of the Company; Enrolls First Patient in Prehospital Trial on Stroke Triage
MindRhythm is medical technology company focused on preventing neurological injury in stroke.
Medtronic Receives FDA Approval to Launch Clinical Study for Implantable Tibial Neuromodulation Therapy for Bladder Incontinence
The TITAN 1 Feasibility Study is a prospective, multicenter, feasibility study to characterize the procedure for the implantable TNM device in subjects with bladder incontinence.
CareDx to Present New Heart Transplant Data at the International Society for Heart and Lung Transplantation Annual Meeting
Experts will present its latest heart research, which was accepted at the International Society for Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, set to take place between April 24-28, 2021.
MicroTransponder Reports: Positive Stroke Rehabilitation Clinical Trial Results for the Vivistim® Paired VNS™ System Published in The Lancet
The Lancet reports that patients receiving Vivistim® Paired VNS™ System therapy showed 2-3 times the improvement in upper extremity motor impairment and function compared to controls that received intense rehabilitation alone.
RhoVac Reports to Mount Sinai Hospital in New York Join Phase IIb Study in Prostate Cancer
The participation of Mount Sinai was directly caused by the FDA approval of RhoVac's Fast Track Designation.
IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae...
The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.